Cadrenal Therapeutics, INC. (CVKD) SEC Filings — 2026
4 SEC filings for Cadrenal Therapeutics, INC. (CVKD) in 2026.
Filings
- Cadrenal Therapeutics Files 8-K on Warrants and Equity — 8-K · Apr 1, 2026
- Cadrenal Therapeutics Files Prospectus Supplement — 424B5 · Apr 1, 2026
- Cadrenal Pivots to CAD-1005, Eyes Phase 3 for Deadly Blood Disorder — 10-K · Mar 31, 2026
- Cadrenal Therapeutics, INC. 8-K Filing — 8-K · Mar 31, 2026